SCHEMBL30745364

SCHEMBL30745364

CC(C)(C)OC(=O)N1CCCCC1Cn1ccc(CO)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE8B O95263 1/20 0.46
▸ KDM1A O60341 1/20 0.42
▸ ATM Q13315 2/20 0.40
▸ CHEK2 O96017 1/20 0.39
▸ METTL3 Q86U44 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ PRMT5 O14744 1/20 0.38
▸ ALOX5AP P20292 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ IL1B P01584 2/20 0.37
▸ P2RX7 Q99572 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ FPR3 P25089 1/20 0.37
▸ FPR2 P25090 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30745428 0.87 PDE8B (0.42) PDE8BKDM1AATMCHEK2METTL3
SCHEMBL30745373 0.84 KMT2A (0.49) PDE8BKDM1AATMCHEK2METTL3
SCHEMBL30745354 0.81 ALDH1A1 (0.44) PDE8BALDH1A1LMNAMEN1TSHR
SCHEMBL22761790 0.80 MEN1 (0.42) PDE8BKDM1AOPRD1PRMT5ALOX5AP
SCHEMBL24791666 0.78 KDM4E (0.48) FPR2
SCHEMBL30740781 0.78 KDM1A (0.44) PDE8BKDM1AATMCHEK2METTL3
SCHEMBL30740850 0.76 CHEK2 (0.42) PDE8BKDM1AATMCHEK2METTL3
SCHEMBL7915136 0.75 PDE8B (0.51) PDE8BKDM1AATMOPRD1
SCHEMBL192841 0.75 POLB (0.51) PDE8BKDM1AATMALDH1A1TSHR
SCHEMBL282976 0.75 POLB (0.51) PDE8BKDM1AATMALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117545748-A Benzimidazolyl GLP-1GPCR receptor agonists, pharmaceutical compositions comprising the same, and methods of use thereof 卡莫特医疗有限公司 2024-02-09 — — CN disclosed
Send feedback